Clinical Trial Update: Clinical Study of ATTR-CM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for transthyroxine amyloidosis cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyroxine Amyloidosis Cardiomyopathy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Transthyroxine Amyloidosis Cardiomyopathy | Phase 4 | Status: RECRUITING